Prostate Cancer Therapy Using Docetaxel and Formononetin Combination: Hyaluronic Acid and Epidermal Growth Factor Receptor Targeted Peptide Dual Ligands Modified Binary Nanoparticles to Facilitate the in vivo Anti-Tumor Activity
Zhaoqiang Dong,1 Yuzhen Wang,2 Jing Guo,3 Chuan Tian,4 Wengu Pan,4 Hongwei Wang,4 Jieke Yan4 1Department of Cardiology, The Second Hospital of Shandong University, Ji'nan, 250033, People's Republic of China; 2Clinical Department, Jinan Vocation College of Nursing, Ji'nan, 250033, Peop...
Saved in:
Main Authors: | Dong Z (Author), Wang Y (Author), Guo J (Author), Tian C (Author), Pan W (Author), Wang H (Author), Yan J (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2022-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Focusing on Formononetin: Recent Perspectives for its Neuroprotective Potentials
by: Jiao Tian, et al.
Published: (2022) -
Acute myocardial infarction therapy: in vitro and in vivo evaluation of atrial natriuretic peptide and triphenylphosphonium dual ligands modified, baicalin-loaded nanoparticulate system
by: Jie Wang, et al.
Published: (2021) -
Dipeptide-modified nanoparticles to facilitate oral docetaxel delivery: new insights into PepT1-mediated targeting strategy
by: Yuqian Du, et al.
Published: (2018) -
Dual-ligand modified liposomes provide effective local targeted delivery of lung-cancer drug by antibody and tumor lineage-homing cell-penetrating peptide
by: Congcong Lin, et al.
Published: (2018) -
Mucin Production Correlates with Dual Expression of Epidermal Growth Factor Receptor and Its Ligand the Epidermal Growth Factor in Non-Small Cell Lung Cancer
by: Rancés Blanco, et al.
Published: (2017)